13FARBUTUS BIOPHARMA CORP (ABUS)
3 tracked managers currently hold ABUS on their latest filing. Change is versus that manager’s previous filing. Reported as of quarter end, filed up to ~45 days later, not live positions.
Sort: Size Weight change
Sorted by reported value on the latest filing.
| Manager | Period | Change | Value | Weight | Prev weight | Shares | Δ shares |
|---|---|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | Q2 2026 | TRIM | $1.9M | 0.0 % | 0.0 % | 404,696 | -272,442 |
| D. E. Shaw & Co., Inc. | Q2 2026 | ADD | $1.8M | 0.0 % | 0.0 % | 381,863 | +238,662 |
| TWO SIGMA INVESTMENTS, LP | Q2 2026 | NEW | $407.9K | 0.0 % | — | 84,986 | NEW |